Webinar: Safety in Life Sciences How to mitigate significant injury and fatality in workplace Safety risk management and analysis Effective safety program management Hazard identification and control systems OSHA’s approach to COVID and the OSHA ETS (Emergency Temporary Standard) OSHA enforcement and regulatory agenda under the new Administration ISPE Members: $10 I Non-Members: $20 SPEAKERS Mitigating Significant Injury and Fatality Risks Victor D’Amato, CIH, CSP, Head of Safety, Health & Environment AstraZeneca Global Operations What’s New with OSHA Richard Fairfax, CIH, Director of Life Science Division, Energy Efficiency Consultancy Ltd (EECO2) MODERATORS Hamid Teimourian, Senior Engineer, AstraZeneca and ISPE-CBA Board of Directors Jeff Williford, Vice President, Life Sciences, Buch Construction and ISPE-CBA Board of Directors Register